Chimenti MS - Search Results

1

Use of synthetic and biological DMARDs in patients with enteropathic spondyloarthritis: a combined gastro-rheumatological approach.

Chimenti MS, Conigliaro P, Triggianese P, Canofari C, Cedola F, Onali S, Calabrese E, Romeo S, Neri B, De Cristofaro E, Biancone L, Perricone R. Chimenti MS, et al. Clin Exp Rheumatol. 2019 Sep-Oct;37(5):723-730. Epub 2019 Jun 6. Clin Exp Rheumatol. 2019. PMID: 31172920

2

Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: is it possible after disease remission?

Chimenti MS, Graceffa D, Perricone R. Chimenti MS, et al. Autoimmun Rev. 2011 Aug;10(10):636-40. doi: 10.1016/j.autrev.2011.04.015. Epub 2011 Apr 21. Autoimmun Rev. 2011. PMID: 21536151 Review.

3

Role of the complement system in rheumatoid arthritis and psoriatic arthritis: relationship with anti-TNF inhibitors.

Ballanti E, Perricone C, di Muzio G, Kroegler B, Chimenti MS, Graceffa D, Perricone R. Ballanti E, et al. Among authors: chimenti ms. Autoimmun Rev. 2011 Aug;10(10):617-23. doi: 10.1016/j.autrev.2011.04.012. Epub 2011 Apr 27. Autoimmun Rev. 2011. PMID: 21549221 Review.

4

Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways.

Chimenti MS, Ballanti E, Perricone C, Cipriani P, Giacomelli R, Perricone R. Chimenti MS, et al. Autoimmun Rev. 2013 Mar;12(5):599-606. doi: 10.1016/j.autrev.2012.10.002. Epub 2012 Nov 24. Autoimmun Rev. 2013. PMID: 23183378 Review.

5

Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.

Esposito M, Giunta A, Mazzotta A, Zangrilli A, Babino G, Bavetta M, Perricone R, Chimenti S, Chimenti MS. Esposito M, et al. Among authors: chimenti ms, chimenti s. Dermatology. 2012;225(4):312-9. doi: 10.1159/000345623. Epub 2012 Dec 28. Dermatology. 2012. PMID: 23295383

6

Complement and autoimmunity.

Ballanti E, Perricone C, Greco E, Ballanti M, Di Muzio G, Chimenti MS, Perricone R. Ballanti E, et al. Among authors: chimenti ms. Immunol Res. 2013 Jul;56(2-3):477-91. doi: 10.1007/s12026-013-8422-y. Immunol Res. 2013. PMID: 23615835 Review.

7

Profile of certolizumab and its potential in the treatment of psoriatic arthritis.

Chimenti MS, Saraceno R, Chiricozzi A, Giunta A, Chimenti S, Perricone R. Chimenti MS, et al. Among authors: chimenti s. Drug Des Devel Ther. 2013 Apr 15;7:339-48. doi: 10.2147/DDDT.S31658. Print 2013. Drug Des Devel Ther. 2013. PMID: 23620660 Free PMC article. Review.

8

Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab.

Chimenti MS, Tucci P, Candi E, Perricone R, Melino G, Willis AE. Chimenti MS, et al. Cell Cycle. 2013 Sep 15;12(18):3025-36. doi: 10.4161/cc.26067. Epub 2013 Aug 19. Cell Cycle. 2013. PMID: 23974102 Free PMC article.

9

The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies.

Novelli L, Chimenti MS, Chiricozzi A, Perricone R. Novelli L, et al. Among authors: chimenti ms. Autoimmun Rev. 2014 Jan;13(1):64-9. doi: 10.1016/j.autrev.2013.08.006. Epub 2013 Sep 8. Autoimmun Rev. 2014. PMID: 24021172 Review.

10

Golimumab in patients affected by moderate to severe psoriatic arthritis: an open-label study in thirty-two patients previously treated with other biologics.

Chimenti MS, Teoli M, Saraceno R, Dattola A, Ventura A, Chiricozzi A, Chiaramonte C, Perricone R, Chimenti S. Chimenti MS, et al. Among authors: chimenti s. Dermatology. 2013;227(4):305-10. doi: 10.1159/000354263. Epub 2013 Nov 19. Dermatology. 2013. PMID: 24280959 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

239 results

Search Page

Filters